U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Immunosuppressive Agents [Pharmacological Action]

Tree Number(s): D007166

MeSH Unique ID: D007166

  • bis(p-chlorophenyl)acetic acid (Supplementary Concept)
  • N,N'-dimethylnitrosourea (Supplementary Concept)
  • triptolide (Supplementary Concept)
  • thermozymocidin (Supplementary Concept)
  • trofosfamide (Supplementary Concept)
  • butenolide (Supplementary Concept)
  • azodicarbonamide (Supplementary Concept)
  • desthiobiotin (Supplementary Concept)
  • hypericin (Supplementary Concept)
  • methyl cellosolve (Supplementary Concept)
  • bis(tri-n-butyltin)oxide (Supplementary Concept)
  • dimethyl sulfate (Supplementary Concept)
  • monodansylcadaverine (Supplementary Concept)
  • pristane (Supplementary Concept)
  • tetrandrine (Supplementary Concept)
  • benzonidazole (Supplementary Concept)
  • mizoribine (Supplementary Concept)
  • 9-(2-hydroxy-3-nonyl)adenine (Supplementary Concept)
  • 5-mercapto-2'-deoxyuridine (Supplementary Concept)
  • methoxyacetic acid (Supplementary Concept)
  • lobenzarit (Supplementary Concept)
  • leukotoxin (Supplementary Concept)
  • traxanox (Supplementary Concept)
  • dibutyldichlorotin (Supplementary Concept)
  • tanshinone (Supplementary Concept)
  • (T,G)-A-L (Supplementary Concept)
  • deflazacort (Supplementary Concept)
  • tobacco tar (Supplementary Concept)
  • doxifluridine (Supplementary Concept)
  • early pregnancy factor (Supplementary Concept)
  • lisofylline (Supplementary Concept)
  • saikosaponin D (Supplementary Concept)
  • L-glutamic acid-L-tyrosine copolymer (Supplementary Concept)
  • uterine luminal fluid proteins (Supplementary Concept)
  • didemnins (Supplementary Concept)
  • 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole (Supplementary Concept)
  • 8-aminoguanosine (Supplementary Concept)
  • stepronin (Supplementary Concept)
  • bestrabucil (Supplementary Concept)
  • gusperimus (Supplementary Concept)
  • pirmagrel (Supplementary Concept)
  • castanospermine (Supplementary Concept)
  • fludarabine phosphate (Supplementary Concept)
  • leucyl-leucine-methyl ester (Supplementary Concept)
  • PAEP protein, human (Supplementary Concept)
  • cyclosporin G (Supplementary Concept)
  • brequinar (Supplementary Concept)
  • undecylprodigiosin (Supplementary Concept)
  • repirinast (Supplementary Concept)
  • 2-acetyl-4(5)-tetrahydroxybutylimidazole (Supplementary Concept)
  • OM 89 (Supplementary Concept)
  • daltroban (Supplementary Concept)
  • U 74500A (Supplementary Concept)
  • enisoprost (Supplementary Concept)
  • 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol (Supplementary Concept)
  • cyclolinopeptide A (Supplementary Concept)
  • glimepiride (Supplementary Concept)
  • immunomycin (Supplementary Concept)
  • acteoside (Supplementary Concept)
  • 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (Supplementary Concept)
  • SK and F 105685 (Supplementary Concept)
  • BCRF1 protein, Human herpesvirus 4 (Supplementary Concept)
  • ONO-LB 457 (Supplementary Concept)
  • tepoxalin (Supplementary Concept)
  • KH 1060 (Supplementary Concept)
  • U 74389F (Supplementary Concept)
  • SDZ IMM 125 (Supplementary Concept)
  • seocalcitol (Supplementary Concept)
  • inolimomab (Supplementary Concept)
  • SR 31747 (Supplementary Concept)
  • alicaforsen (Supplementary Concept)
  • abetimus (Supplementary Concept)
  • semapimod (Supplementary Concept)
  • X 910279 (Supplementary Concept)
  • FR 167653 (Supplementary Concept)
  • pimecrolimus (Supplementary Concept)
  • belimumab (Supplementary Concept)
  • thymoglobulin (Supplementary Concept)
  • umirolimus (Supplementary Concept)
  • teriflunomide (Supplementary Concept)
  • golimumab (Supplementary Concept)
  • peficitinib (Supplementary Concept)
  • rozanolixizumab (Supplementary Concept)
  • FX006 (Supplementary Concept)
  • adalimumab biosimilar HS016 (Supplementary Concept)
  • ALPN-101 (Supplementary Concept)
  • Antilymphocyte Serum (MeSH Term)
  • Azaserine (MeSH Term)
  • Azathioprine (MeSH Term)
  • Busulfan (MeSH Term)
  • Coformycin (MeSH Term)
  • Cyclophosphamide (MeSH Term)
  • Cyclosporins (MeSH Term)
  • Cytarabine (MeSH Term)
  • Ellipticines (MeSH Term)
  • Fluorouracil (MeSH Term)
  • Gliotoxin (MeSH Term)
  • Methotrexate (MeSH Term)
  • Thalidomide (MeSH Term)
  • Thioinosine (MeSH Term)
  • Triamcinolone Acetonide (MeSH Term)
  • Mercaptopurine (MeSH Term)
  • Tacrolimus (MeSH Term)
  • Cyclosporine (MeSH Term)
  • Muromonab-CD3 (MeSH Term)
  • Cladribine (MeSH Term)
  • Sirolimus (MeSH Term)
  • Everolimus (MeSH Term)
  • Certolizumab Pegol (MeSH Term)
  • Glatiramer Acetate (MeSH Term)
  • Etanercept (MeSH Term)
  • Fingolimod Hydrochloride (MeSH Term)
  • Dimethyl Fumarate (MeSH Term)
  • Abatacept (MeSH Term)
  • Wortmannin (MeSH Term)
  • Leflunomide (MeSH Term)
  • Basiliximab (MeSH Term)
  • Daclizumab (MeSH Term)
  • cobra venom factor (Supplementary Concept)
  • K 76 carboxylic acid (Supplementary Concept)
  • C5a peptidase (Supplementary Concept)
  • nafamostat (Supplementary Concept)
  • vilobelimab (Supplementary Concept)
  • eculizumab (Supplementary Concept)
  • ravulizumab (Supplementary Concept)
  • (4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium (Supplementary Concept)
  • 2-(3-oxo-1-(toluene-4-sulfonyl)-1,2,3,4-4H-quinoxalin-2-yl)-N-phenyl-acetamide (Supplementary Concept)
  • 1-(4-methyl-3-(2-methyl-4-(4-methyl-2H-pyrazol-3-yl)-quinolin-8-yloxymethyl)pyridin-2-ylmethyl)-3-trifluoromethyl-1H-pyridin-2-one (Supplementary Concept)
  • N-(2-(4-(2-amino-5-(dimethylamino)pentanoyl)piperazin-1-yl)-1,1-dimethyl-2-oxoethyl)-2,3-dichloro-3-(2,4-dimethylquinolin-8-yloxymethyl)benzenesulfonamide (Supplementary Concept)
  • icatibant (Supplementary Concept)
  • temsirolimus (Supplementary Concept)
  • NIBR-0213 (Supplementary Concept)
  • ceralifimod (Supplementary Concept)
  • ozanimod (Supplementary Concept)
  • VPC23019 (Supplementary Concept)
  • SEW2871 (Supplementary Concept)
  • ponesimod (Supplementary Concept)
  • siponimod (Supplementary Concept)
  • AUY 954 (Supplementary Concept)
  • Complement Factor H (MeSH Term)
  • Complement Factor I (MeSH Term)
  • CD59 Antigens (MeSH Term)
  • Complement Inactivator Proteins (MeSH Term)
  • Complement C1 Inactivator Proteins (MeSH Term)
  • Complement C3 Nephritic Factor (MeSH Term)
  • Complement C3b Inactivator Proteins (MeSH Term)
  • Complement C4b-Binding Protein (MeSH Term)
  • Complement C1 Inhibitor Protein (MeSH Term)
  • Thiotepa (MeSH Term)
  • Melphalan (MeSH Term)

Supplemental Content

Loading ...